These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 15538725)
1. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine. Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725 [TBL] [Abstract][Full Text] [Related]
2. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831 [TBL] [Abstract][Full Text] [Related]
3. A 1.3 kb promoter fragment confers spatial and temporal expression of utrophin A mRNA in mouse skeletal muscle fibers. Stocksley MA; Chakkalakal JV; Bradford A; Miura P; De Repentigny Y; Kothary R; Jasmin BJ Neuromuscul Disord; 2005 Jun; 15(6):437-49. PubMed ID: 15907291 [TBL] [Abstract][Full Text] [Related]
4. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
5. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959 [TBL] [Abstract][Full Text] [Related]
7. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118 [TBL] [Abstract][Full Text] [Related]
8. [Utrophin, a way to cure Duchenne muscle dystrophy]. Gillis JM Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117 [TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295 [TBL] [Abstract][Full Text] [Related]
10. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518 [TBL] [Abstract][Full Text] [Related]
11. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice. Gillis JM Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286 [TBL] [Abstract][Full Text] [Related]
13. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Miura P; Jasmin BJ Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393 [TBL] [Abstract][Full Text] [Related]
14. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. Wang B; Li J; Fu FH; Xiao X J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234 [TBL] [Abstract][Full Text] [Related]
15. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy. Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000 [TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610 [TBL] [Abstract][Full Text] [Related]
17. Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres. Baranov A; Glazkov P; Kiselev A; Ostapenko O; Mikhailov V; Ivaschenko T; Sabetsky V; Baranov V Gene Ther; 1999 Aug; 6(8):1406-14. PubMed ID: 10467365 [TBL] [Abstract][Full Text] [Related]
18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice. Albesa M; Ogrodnik J; Rougier JS; Abriel H Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for Duchenne and Becker dystrophies. Voisin V; de la Porte S Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]